| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (4952 + methicillin-resistant) |
- |
- |
4 － ? |
Cefotiam  |
1398 |
| Staphylococcus aureus (4952 + methicillin-resistant) |
- |
- |
4 － ? |
Cefpirome |
1398 |
| Staphylococcus aureus (4952 + methicillin-resistant) |
- |
- |
4 － ? |
Flomoxef |
1398 |
| Staphylococcus aureus (4952 + methicillin-resistant) |
- |
- |
8 － ? |
Cefmetazole |
1398 |
| Staphylococcus aureus (4952 + methicillin-resistant) |
- |
- |
16 － ? |
Ampicillin (Omnipen) |
1398 |
| Staphylococcus aureus (4952 + methicillin-resistant) |
- |
- |
16 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1398 |
| Staphylococcus aureus (5) |
- |
- |
0.06 － ? |
Mupirocin (Bactroban) |
120 |
| Staphylococcus aureus (5) |
- |
- |
0.06 － ? |
Sanfetrinem cilexetil |
317 |
| Staphylococcus aureus (5) |
- |
- |
0.12 － ? |
Retapamulin |
120 |
| Staphylococcus aureus (5) |
- |
- |
0.12 － ? |
Retapamulin |
120 |
| Staphylococcus aureus (5) |
- |
- |
0.125 － ? |
Cefdinir (Omnicef, Cefdiel) |
317 |
| Staphylococcus aureus (5) |
- |
- |
16 － ? |
Ampicillin (Omnipen) |
220 |
| Staphylococcus aureus (5) |
- |
- |
>16 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
220 |
| Staphylococcus aureus (5023 + methicillin-resistant) |
- |
- |
0.25 － ? |
Daptomycin (Cubicin) |
1034 |
| Staphylococcus aureus (5023 + methicillin-resistant) |
- |
- |
1 － ? |
Quinupristin/Dalfopristin (Synercid) |
1034 |
| Staphylococcus aureus (5023 + methicillin-resistant) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
1034 |
| Staphylococcus aureus (5023 + methicillin-resistant) |
- |
- |
2 － ? |
Gatifloxacin (Tequin) |
1034 |
| Staphylococcus aureus (5023 + methicillin-resistant) |
- |
- |
2 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
1034 |
| Staphylococcus aureus (5023 + methicillin-resistant) |
- |
- |
5 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
1034 |
| Staphylococcus aureus (5023 + methicillin-resistant) |
- |
- |
16 － ? |
Levofloxacin (Levaquin, Quixin) |
1034 |
| Staphylococcus aureus (503) |
- |
- |
0.01 － ? |
Imipenem |
1231 |
| Staphylococcus aureus (503) |
- |
- |
0.05 － ? |
Meropenem (Merrem) |
1231 |
| Staphylococcus aureus (503) |
- |
- |
0.098 － ? |
Cefpirome |
333 |
| Staphylococcus aureus (503) |
- |
- |
0.781 － ? |
Cefotaxime (Cephotaxime, Claforan) |
333 |
| Staphylococcus aureus (5185) |
- |
- |
2 － ? |
Amphipathic-2D (Peptide) |
296 |
| Staphylococcus aureus (5185) |
- |
- |
3 － ? |
Amphipathic-3D (Peptide) |
296 |
| Staphylococcus aureus (5185) |
- |
- |
4 － ? |
Amphipathic-1D (Peptide) |
296 |
| Staphylococcus aureus (5185) |
- |
- |
4 － ? |
Scrambled-4D (Peptide) |
296 |